RWE Study Delivery Lead – France & Germany

Resilience Healthcare L.L.C.; Paris, Toulouse; Hybrid; EUR 90,000 - 130,000; Full time

Job summary

Resilience Care in France seeks an expert to lead Real-World Evidence studies in Germany and France, coordinating protocol, ethics, data collection and reporting. You will manage timelines, budgets, site contracts and CRO partners, ensuring high-quality deliverables for oncology and haematology research.

You will work with cross-functional teams across Medical, Data, Legal and Quality, turning delivery experience into reusable methods while communicating with sponsor stakeholders.

Qualifications

• Lead a clinical or non-interventional study end to end.
• Navigate the German research environment and GDPR/DSGVO.
• Oversee a CRO and its deliverables with sponsor responsibilities.
• Track study budgets and variances.
• Assess clinical data quality and discuss data structuring.
• Communicate effectively with international partners and teams.

Responsibilities

• Lead studies from contracting to final report, coordinating protocol and SAP.
• Maintain an actionable project timeline and mitigate risks.
• Track budgets, site costs, and CRO expenses.
• Coordinate site contracting and CRO partner activities.
• Act as sponsor's primary operational contact and lead steering committees.
• Collaborate with Medical, Clinical Ops, Data, Legal and Quality teams.

Skills

Lead studies end to end

German ecosystem navigation

Budget tracking

CRO management

Stakeholder communication

GDPR/DSGVO knowledge

Job description

Resilience Care in France seeks an expert to lead Real-World Evidence studies in Germany and France, coordinating protocol, ethics, data collection and reporting. You will manage timelines, budgets, site contracts and CRO partners, ensuring high-quality deliverables for oncology and haematology research.

You will work with cross-functional teams across Medical, Data, Legal and Quality, turning delivery experience into reusable methods while communicating with sponsor stakeholders.